The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: A single-center retrospective study

Annals of Hematology

Volumn 92, Issue 6, 2013, Pages 817-824

  Shin, Seung Hwan ^a   Yoon, Jae Ho ^a   Yahng, Seung Ah ^a   Lee, Sung Eun ^a   Cho, Byung Sik ^a   Eom, Ki Sung ^a   Kim, Yoo Jin ^a   Lee, Seok ^a   Min, Chang Ki ^a   Kim, Hee Je ^a   Cho, Seok Goo ^a   Kim, Dong Wook ^a   Min, Woo Sung ^a   Park, Chong Won ^a   Lee, Jong Wook ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Hematologic response; Immunosuppressive therapy; Rabbit antithymocyte globulin; Severe aplastic anemia

Indexed keywords

CYCLOSPORIN; HORSE ANTITHYMOCYTE GLOBULIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOGLOBULINE; METHYLPREDNISOLONE; RABBIT ANTITHYMOCYTE GLOBULIN; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FAILURE FREE SURVIVAL; FEMALE; HUMAN; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANIMALS; ANTILYMPHOCYTE SERUM; CLONAL EVOLUTION; CYCLOSPORINE; DRUG EVALUATION; FEMALE; HORSES; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RABBITS; RECURRENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SPECIES SPECIFICITY; T-LYMPHOCYTES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877762081     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1674-8     Document Type: Article

References (34)

1. Young NS (2002) Acquired aplastic anemia. Ann Intern Med 136(7):534-546
2. Young NS, Calado RT, Scheinberg P (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108(8):2509-2519. doi: 10.1182/blood-2006-03-010777
3. Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H (2003) Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 101(4):1236-1242. doi: 10.1182/blood-2002-04-1134
4. Zheng Y, Liu Y, Chu Y (2006) Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens. Exp Hematol 34(7):826-831. doi: 10.1016/j.exphem.2006.03.017
5. Rosenfeld S, Follmann D, Nunez O, Young NS (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 289(9):1130-1135
6. Speck B, Gratwohl A, Nissen C, Leibundgut U, Ruggero D, Osterwalder B, Burri HP, Cornu P, Jeannet M (1981) Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation. Br Med J (Clin Res Ed) 282(6267):860-863
7. Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A, Schrezenmeier H, Passweg J, Fuhrer M (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 92(1):11-18
8. Scheinberg P, Nunez O, Young NS (2006) Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol 133(6):622-627. doi: 10.1111/j.1365-2141.2006.06098.x
9. Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, Raghavachari N, Munson PJ, Herndon TM, Chen J, Young NS (2008) Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro. Blood 111(7):3675-3683. doi: 10.1182/blood-2008-01-130146
10. Mohty M (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21(7):1387-1394. doi: 10.1038/sj.leu.2404683
11. Afable MG 2nd, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, Sekeres MA, Lichtin A, Advani A, Kalaycio M, Tiu RV, O'Keefe CL, Maciejewski JP (2011) Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Haematologica 96(9):1269-1275. doi: 10.3324/haematol.2011.042622
12. Atta EH, Dias DS, Marra VL, de Azevedo AM (2010) Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol 89(9):851-859. doi: 10.1007/s00277-010-0944-y
13. Scheinberg P, Nunez O, Weinstein B, Biancotto A, Wu CO, Young NS (2011) Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 365(5):430-438. doi: 10.1056/NEJMoa1103975
14. Marsh JC, Bacigalupo A, Schrezenmeier H, Tichelli A, Risitano AM, Passweg JR, Killick SB, Warren AJ, Foukaneli T, Aljurf M, Al-Zahrani HA, Schafhausen P, Roth A, Franzke A, Brummendorf TH, Dufour C, Oneto R, Sedgwick P, Barrois A, Kordasti S, Elebute MO, Mufti GJ, Socie G (2012) Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood 119(23):5391-5396. doi: 10.1182/blood-2012-02-407684
15. Battiwalla M, Hepgur M, Pan D, McCarthy PL, Ahluwalia MS, Camacho SH, Starostik P, Wallace PK (2010) Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations. Cytometry B Clin Cytom 78(5):348-356. doi: 10.1002/cyto.b.20519
16. Oelschlaegel U, Besson I, Arnoulet C, Sainty D, Nowak R, Naumann R, Bux Y, Ehninger G (2001) A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes. Clin Lab Haematol 23(2):81-90
17. Bacigalupo A, Passweg J (2009) Diagnosis and treatment of acquired aplastic anemia. Hematol Oncol Clin North Am 23(2):159-170. doi: 10.1016/j.hoc.2009.01.005
18. Scheinberg P, Wu CO, Nunez O, Boss C, Sloand EM, Young NS (2009) Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica 94(3):348-354. doi: 10.3324/haematol.13829
19. Marsh J, Schrezenmeier H, Marin P, Ilhan O, Ljungman P, McCann S, Socie G, Tichelli A, Passweg J, Hows J, Raghavachar A, Locasciulli A, Bacigalupo A (1999) Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93(7):2191-2195
20. Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F, Gabbas A, Dufour C, Arcese W, Testi G, Broccia G, Carotenuto M, Coser P, Barbui T, Leoni P, Ferster A (2000) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood 95(6):1931-1934
21. Kojima S, Hibi S, Kosaka Y, Yamamoto M, Tsuchida M, Mugishima H, Sugita K, Yabe H, Ohara A, Tsukimoto I (2000) Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 96(6):2049-2054
22. Scheinberg P, Nunez O, Wu C, Young NS (2006) Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. Br J Haematol 133(6):606-611. doi: 10.1111/j.1365-2141.2006.06085.x
23. Scheinberg P, Fischer SH, Li L, Nunez O, Wu CO, Sloand EM, Cohen JI, Young NS, John Barrett A (2007) Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 109(8):3219-3224. doi: 10.1182/blood-2006-09-045625
24. Feng X, Scheinberg P, Biancotto A, Rios O, Donaldson S, Wu CO, Zheng H, Sato K, McCoy J, Young NS (2011) Different in vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia. ASH Annual Meeting Abstracts 118(21):2399
25. Solomou EE, Rezvani K, Mielke S, Malide D, Keyvanfar K, Visconte V, Kajigaya S, Barrett AJ, Young NS (2007) Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood 110(5):1603-1606. doi: 10.1182/blood-2007-01-066258
26. Chen J, Ellison FM, Eckhaus MA, Smith AL, Keyvanfar K, Calado RT, Young NS (2007) Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells. J Immunol 178(7):4159-4168
27. Jeong DC, Chung NG, Lee JW, Jang PS, Cho B, Kim HK (2011) Long-term outcome of immunosuppressive therapy with rabbit antithymocyte globulin (rATG) for childhood severe aplastic anemia for 15 years. ASH Annual Meeting Abstracts 118(21):1346
28. Yamazaki H, Saito C, Sugimori N, Hosokawa K, Kiyu Y, Mochizuki K, Takamatsu H, Nakao S (2011) Thymoglobuline is as effective as lymphoglobuline in japanese patients with aplastic anemia possessing increased glycosylphosphatidylinositol-anchored protein (GPI-AP) deficient cells. ASH Annual Meeting Abstracts 118(21):1339
29. Maluf EM, Pasquini R, Eluf JN, Kelly J, Kaufman DW (2002) Aplastic anemia in Brazil: incidence and risk factors. Am J Hematol 71(4):268-274. doi: 10.1002/ajh.10232
30. Young NS, Kaufman DW (2008) The epidemiology of acquired aplastic anemia. Haematologica 93(4):489-492. doi: 10.3324/haematol.12855
31. Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Leaverton PE, Shapiro S, Young NS (2006) The epidemiology of aplastic anemia in Thailand. Blood 107(4):1299-1307. doi: 10.1182/blood-2005-01-0161
32. Yang C, Zhang X (1991) Incidence survey of aplastic anemia in China. Chin Med Sci J 6(4):203-207
33. Saracco P, Quarello P, Iori AP, Zecca M, Longoni D, Svahn J, Varotto S, Del Vecchio GC, Dufour C, Ramenghi U, Bacigalupo A, Locasciulli A (2008) Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up. Br J Haematol 140(2):197-205. doi: 10.1111/j.1365-2141.2007.06903.x
34. Scheinberg P, Wu CO, Nunez O, Young NS (2009) Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 144(2):206-216. doi: 10.1111/j.1365-2141.2008.07450.x